Industry Watch [to 28 February 2015]
:: Merck’s 9-Valent HPV Vaccine, GARDASIL®9, Recommended by CDC’s Advisory Committee on Immunization Practices for Females Aged 9-26 and Males Aged 9-21
February 26, 2015

:: CDC Advisory Committee on Immunization Practices Votes to Recommend Serogroup B Meningococcal Disease Vaccination for Persons at Increased Risk [Pfizer]
February 26, 2015

:: Pfizer Announces Positive Top-line Results Of A Phase 2 Study Of TRUMENBA® (Meningococcal Group B Vaccine) Co-Administered With Routine Meningococcal (A, C, Y, and W) And Tetanus, Diptheria And Pertussis (Tdap) Vaccines In Adolescents
February 24, 2015

:: Sanofi joins Be He@lthy, Be Mobile initiative
Partnership harnessing power of ICTs to deliver health-care solutions
Geneva, 26 February 2015 – Multinational pharmaceutical firm Sanofi has joined the International Telecommunication Union’s Be He@lthy, Be Mobile initiative, which ITU leads in collaboration with the World Health Organization (WHO).
Be He@lthy Be Mobile partners include Bupa, Verizon, The World Lung Foundation, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), the Non-Communicable Disease (NCD) Alliance, Novartis and GSK. Participating organizations are currently contributing to the initiative through funds, in-kind contributions and knowledge, as well as supporting country projects. They will join forces to provide multidisciplinary expertise, health information and mobile technology to fight chronic non-communicable diseases (NCDs), including diabetes, cancer, cardiovascular and chronic respiratory diseases, in low- and middle-income countries…